Onconova Therapeutics CEO Steven Fruchtman's 2021 pay jumps 159% to $2.7M
Onconova Therapeutics reports 2021 executive compensation
By ExecPay News
Published: May 25, 2022
Onconova Therapeutics reported fiscal year 2021 executive compensation information on May 25, 2022.
In 2021, three executives at Onconova Therapeutics received on average a compensation package of $1.7M, a 104% increase compared to previous year.
Average pay of disclosed executives at Onconova Therapeutics
Steven M. Fruchtman, Chief Executive Officer, received $2.7M in total, which increased by 159% compared to 2020. 47% of Fruchtman's compensation, or $1.3M, was in stock awards. Fruchtman also received $280K in bonus, $509K in option awards, $600K in salary, as well as $24K in other compensation.
Mark P. Guerin, Chief Financial Officer, received a compensation package of $1.3M, which increased by 109% compared to previous year. 41% of the compensation package, or $528K, was in stock awards.
Abraham N. Oler, General Counsel, earned $1.1M in 2021.
Related executives
You may also like
Source: SEC filing on May 25, 2022.